What one share of Bicycle Therapeutics holds
We are a clinical-stage pharmaceutical company developing a novel class of medicines, which we refer to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained to form two loops which stabilize their structural geometry.
Bicycle Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.88 |
|---|---|
| Profit | −$2.74 |
| Capex (buildings and equipment) | $0.03 |
| Free cash flow | −$3.00 |
| Dividends | $0.00 |
| Cash and investments | $7.31 |
| Book value | $7.31 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $6.18 | −$48.81 | $3.34 | −$7.59 | — | −$141.64 |
| 2018 | $16.26 | −$49.78 | $2.70 | −$62.12 | — | −$85.70 |
| 2019 | $1.25 | −$2.77 | $0.14 | −$2.73 | — | $5.18 |
| 2020 | $0.54 | −$2.66 | $0.06 | −$0.99 | — | $4.53 |
| 2021 | $0.47 | −$2.67 | $0.08 | −$0.67 | — | $11.71 |
| 2022 | $0.49 | −$3.80 | $0.64 | −$3.54 | $0.00 | $9.06 |
| 2023 | $0.76 | −$5.08 | $0.08 | −$1.79 | $0.00 | $8.74 |
| 2024 | $0.61 | −$2.90 | $0.02 | −$2.85 | $0.00 | $11.48 |
| 2025 | $1.05 | −$3.16 | $0.03 | −$3.64 | $0.00 | $8.79 |
Common questions about Bicycle Therapeutics
How much does one share of Bicycle Therapeutics earn?
Over the last 12 months, Bicycle Therapeutics lost $2.74 for each share on $0.88 of sales.
Does Bicycle Therapeutics pay a dividend?
Bicycle Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Bicycle Therapeutics’s book value per share?
Bicycle Therapeutics’s book value is $7.31 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Bicycle Therapeutics have?
Each share of Bicycle Therapeutics has $7.31 of cash and investments, as of June 30, 2026.
What is Bicycle Therapeutics’s free cash flow per share?
−$3.00 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Bicycle Therapeutics bought back shares?
Bicycle Therapeutics’s share count rose about 20697% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.